Drugs / Motore
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02409381 | Jun 2015 → May 2016 | osteoarthritis, knee | Ache Laboratorios Farmaceuticos S.A. | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2025-06-25 | Ache Laboratorios Farmaceuticos S.A. | Regulatory Motore (curcuma longa – extrato seco) 250 mg – cápsula dura ache.com.br ↗
O Aché Laboratórios Farmacêuticos S.A. informa que por motivos comerciais, está descontinuando definitivamente a produção e comercialização do medicamento Motore (curcuma longa – extrato seco) 250 mg – cápsula dura. |
All press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2025-06-25 | Ache Laboratorios Farmaceuticos S.A. | Motore (curcuma longa – extrato seco) 250 mg – cápsula dura ache.com.br ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Motore | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02409381 ↗ |
| Route | Oral | “two (02) capsules orally every twelve (12) hours” NCT02409381 ↗ |